Comparison between Infra Market IPO and Integris Medtech IPO.
Infra Market IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Integris Medtech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Infra Market IPO is up to ₹0.00 Cr whereas the issue size of the Integris Medtech IPO is up to ₹0.00 Cr. The final issue price of Infra Market IPO is and of Integris Medtech IPO is .
| Infra Market IPO | Integris Medtech IPO | |
|---|---|---|
| Face Value | ₹1 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹925.00 Cr |
| OFS Issue Size | 0 shares | 2,16,74,531 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Infra Market IPO opens on , while Integris Medtech IPO opens on . The closing date of Infra Market IPO and Integris Medtech IPO is , and , respectively.
Infra Market IPO P/E ratio is , as compared to Integris Medtech IPO P/E ratio of .
| Infra Market IPO | Integris Medtech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials (Restated Consolidated)Integris Medtech Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 1547% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.24 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 5.35% | ||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.51% | ||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.52 | ||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 1.48% | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Infra Market IPO Retail Individual Investors (RII) are offered while in Integris Medtech IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Infra Market IPO and 0 shares in Integris Medtech IPO.
| Infra Market IPO | Integris Medtech IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Infra Market IPO subscribed in total, whereas Integris Medtech IPO subscribed .
